KD Pharma Group – Top-Up Single-Asset Fund

capiton has successfully closed a new top-up single-asset fund for its fast-growing portfolio company KD Pharma Group („KD Pharma“). This top-up fund will provide KD Pharma with the equity financing for a number of additional strategic investments, in particular add-on acquisitions as well as organic growth initiatives to transfer KD Pharma‘s unique technology and service portfolio from its core omega-3 market to adjacent market segments, including the medical cannabinoid market and small molecule synthesis.

The transaction was highly oversubscribed by its existing investors, enabling capiton to raise the top-up fund in just three months.

About KD Pharma

KD Pharma is a worldwide leading CDMO and technology leader for the purification of lipids. In particular, KD Pharma focuses on small molecule synthesis and manufacturing highly purified omega-3 fatty acids for pharmaceutical and nutraceutical products.

Since its acquisition in 2013 by capiton IV, a fund managed by capiton, KD Pharma has grown from a single-digit revenue business to one of the industry’s largest players with total sales reaching c. EUR 200m to date. Recent investments include the acquisition of manufacturing assets of Rohner AG as well as manufacturing assets and in-licensing of a novel extraction method from Herbolea Biotech.

In 2019 capiton initiated a GP-led single-asset secondary transaction to provide KD Pharma with the necessary investment horizon and follow-on capital to finance the significant future growth potential expected. Following the successful closing of this GP-led secondary, the company has been held in a single-asset continuation fund structure managed by capiton.


capiton was supported in this transaction by CMS Hasche Sigle (asset-level legal advice), POELLATH (fund-level legal advice), EY (tax, structuring) and BMH Bräutigam (notary). The investors were supported by Debevoise & Plimpton (legal advice).


capiton acquires the majority stake in Kutterer Mauer AG, backing one of the founders, Mr. Mauer in continuing the growth story of the company. Mr. Mauer as well as other management members invest alongside capiton. Kutterer Mauer AG is a globally operating manufacturer of caps and closure solutions with >450 employees. The Group designs and […]

We are delighted to announce the successful acquisition of 4PICO Litho by Raith. Raith, the leading global manufacturer of precision technology for nanofabrication instrumentation, has expanded its product offering by adding direct write laser lithography systems – manufactured by 4PICO Litho – to its business strategy. In 2004 4PICO Litho, located near Eindhoven (NL) started […]

capiton acquires majority stake in Stürtz Group. Stürtz Group, headquartered in Neustadt (Wied), Germany, is a market-leading designer, producer, and marketer of automated solutions for the window production industry across the globe. The company generated approximately EUR 46 million in sales in 2020 and employs around 270 FTEs across five locations globally. Stürtz’ product portfolio […]

Dec Group acquires Extract Technology We are delighted to announce the successful acquisition of Extract Technology by Dec Group. Extract Technology is a leading provider of containment and aseptic systems for the pharmaceutical, biotech, nuclear and chemical markets. Extract is headquartered in Huddersfield (UK) with a second facility in New Lisbon (US), serving the fast-growing […]

capiton acquires majority stake in Axxence Group The management team of the Axxence Group acquires in a MBO along with capiton the leading natural aroma chemicals manufacturer from its founder, Joost van Neck. Axxence Group, headquartered in Emmerich, Germany, is a leading manufacturer and supplier of natural aroma chemicals (NACs) for the global flavour & […]

EVP Group acquires Group Korott We are delighted to announce the successful acquisition of Group Korott by EVP Group. Group Korott is a leading manufacturer and distributor of vitamins, minerals, natural cosmetics, as well as sport supplements for the Spanish consumer healthcare market. In addition to its store-brand partnering business, Korott has its own brand […]

Engelmann, with headquarters in Wiesloch, Germany, is the leading European manufacturer of smart heat meters for the sub-metering industry.

Wundex Group, with headquarters in Senden, Germany, is a leading home care provider for patients with chronic wounds. The company‘s qualified wound managers provide home care services that enable faster and more effective wound treatment and significantly reduce the workload of general care providers and physicians, backed by an integrated digital platform.

Die Cedes AG („Cedes“) mit Sitz in Landquart (Schweiz) ist ein führendes Sensortechnologie Unternehmen in der Aufzugs- und Türenindustrie. Unter Verwendung von Infrarot- und Bildverarbeitungstechnologie werden die Produkte für die Automatisierung von Aufzügen, Rolltreppen und Eingängen eingesetzt. Cedes wurde 1986 gegründet und erwirtschaftete 2019 rund CHF 55 Mio. Umsatz mit rund 320 Mitarbeitern.

Die MIP Gruppe („MIP“) ist ein international aufgestellter Hersteller und Distributor von generischen Arzneimitteln mit Schwerpunkt auf Antiinfektiva. Neben Antibiotika bietet MIP rezeptfreie Medikamente und Medizinprodukte an. Die Produkte werden größtenteils in den zwei eigenen Produktionsstandorten im Saarland, Deutschland, gefertigt. Mit ca. 400 Arzneimittelzulassungen und ca. 251 Mitarbeitern generiert MIP Umsätze i.H.v. über € 40 Mio. in 19 Ländern.

capiton AG (“capiton”) freut sich bekannt zu geben, dass die Gesellschafter der Trioptics GmbH (“Trioptics”) und Jenoptik AG (“Jenoptik”) heute einen Vertrag über den Erwerb von 100% der Anteile an Trioptics durch Jenoptik unterzeichnet haben. Trioptics wurde 1991 von Eugen Dumitrescu gegründet und hat sich seitdem zu einem international führenden Anbieter von Mess- und Fertigungssystemen für optische Komponenten und Sensoren in der digitalen Welt entwickelt.

Die AlphaPet Ventures GmbH („AlphaPet“), mit Sitz in München, ist ein führender Anbieter von Eigen- und Fremdmarken für Hunde- und Katzenfutter, die insbesondere über eigene Online-Plattformen vertrieben werden. Das AlphaPet Management hat das Unternehmen mit einem Umsatzwachstum von ca. 30% p.a. in den letzten sechs Jahren zu einem führenden Anbieter im deutschen Online-Markt für Hunde- und Katzenfutter entwickelt.